nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCB1—kidney cancer	0.181	1	CbGaD
Telmisartan—SLCO1B3—Paclitaxel—kidney cancer	0.0581	0.105	CbGbCtD
Telmisartan—ABCG2—Pazopanib—kidney cancer	0.0411	0.0741	CbGbCtD
Telmisartan—ABCG2—Dactinomycin—kidney cancer	0.0376	0.0678	CbGbCtD
Telmisartan—ABCC2—Paclitaxel—kidney cancer	0.0297	0.0535	CbGbCtD
Telmisartan—ABCG2—Erlotinib—kidney cancer	0.0294	0.0529	CbGbCtD
Telmisartan—ABCB1—Temsirolimus—kidney cancer	0.0282	0.0509	CbGbCtD
Telmisartan—ABCG2—Paclitaxel—kidney cancer	0.0269	0.0484	CbGbCtD
Telmisartan—ABCC2—Sorafenib—kidney cancer	0.0264	0.0475	CbGbCtD
Telmisartan—ABCC2—Vinblastine—kidney cancer	0.0261	0.047	CbGbCtD
Telmisartan—ABCC2—Vincristine—kidney cancer	0.0256	0.0462	CbGbCtD
Telmisartan—ABCG2—Sorafenib—kidney cancer	0.0239	0.043	CbGbCtD
Telmisartan—ABCG2—Vincristine—kidney cancer	0.0232	0.0417	CbGbCtD
Telmisartan—ABCC2—Sunitinib—kidney cancer	0.0214	0.0385	CbGbCtD
Telmisartan—ABCG2—Sunitinib—kidney cancer	0.0193	0.0348	CbGbCtD
Telmisartan—ABCC2—Doxorubicin—kidney cancer	0.016	0.0289	CbGbCtD
Telmisartan—ABCB1—Pazopanib—kidney cancer	0.0148	0.0267	CbGbCtD
Telmisartan—ABCG2—Doxorubicin—kidney cancer	0.0145	0.0261	CbGbCtD
Telmisartan—ABCB1—Dactinomycin—kidney cancer	0.0136	0.0244	CbGbCtD
Telmisartan—ABCB1—Gemcitabine—kidney cancer	0.0107	0.0193	CbGbCtD
Telmisartan—CYP2C19—Sorafenib—kidney cancer	0.0107	0.0192	CbGbCtD
Telmisartan—ABCB1—Erlotinib—kidney cancer	0.0106	0.0191	CbGbCtD
Telmisartan—ABCB1—Paclitaxel—kidney cancer	0.00969	0.0175	CbGbCtD
Telmisartan—ABCB1—Sorafenib—kidney cancer	0.00861	0.0155	CbGbCtD
Telmisartan—ABCB1—Vinblastine—kidney cancer	0.0085	0.0153	CbGbCtD
Telmisartan—ABCB1—Vincristine—kidney cancer	0.00835	0.015	CbGbCtD
Telmisartan—ABCB1—Sunitinib—kidney cancer	0.00697	0.0126	CbGbCtD
Telmisartan—AGTR1—nephron—kidney cancer	0.00672	0.221	CbGeAlD
Telmisartan—PPARG—nephron—kidney cancer	0.00552	0.181	CbGeAlD
Telmisartan—ABCB1—Doxorubicin—kidney cancer	0.00522	0.00941	CbGbCtD
Telmisartan—CYP2C19—urine—kidney cancer	0.00335	0.11	CbGeAlD
Telmisartan—PPARG—Everolimus—Temsirolimus—kidney cancer	0.00236	1	CbGdCrCtD
Telmisartan—AGTR1—nephron tubule—kidney cancer	0.00145	0.0476	CbGeAlD
Telmisartan—AGTR1—renal system—kidney cancer	0.00132	0.0433	CbGeAlD
Telmisartan—AGTR1—kidney—kidney cancer	0.00127	0.0418	CbGeAlD
Telmisartan—AGTR1—cortex of kidney—kidney cancer	0.00124	0.0408	CbGeAlD
Telmisartan—AGTR1—cardiac atrium—kidney cancer	0.00118	0.0388	CbGeAlD
Telmisartan—PPARG—renal system—kidney cancer	0.00108	0.0356	CbGeAlD
Telmisartan—ABCC2—nephron tubule—kidney cancer	0.00105	0.0344	CbGeAlD
Telmisartan—PPARG—kidney—kidney cancer	0.00105	0.0344	CbGeAlD
Telmisartan—ABCC2—renal system—kidney cancer	0.000953	0.0313	CbGeAlD
Telmisartan—ABCC2—kidney—kidney cancer	0.000921	0.0302	CbGeAlD
Telmisartan—ABCC2—cortex of kidney—kidney cancer	0.000897	0.0295	CbGeAlD
Telmisartan—ABCG2—nephron tubule—kidney cancer	0.000764	0.0251	CbGeAlD
Telmisartan—Candesartan—PTGS1—kidney cancer	0.000506	0.556	CrCbGaD
Telmisartan—ABCB1—nephron tubule—kidney cancer	0.000377	0.0124	CbGeAlD
Telmisartan—ABCB1—renal system—kidney cancer	0.000343	0.0113	CbGeAlD
Telmisartan—ABCB1—kidney—kidney cancer	0.000331	0.0109	CbGeAlD
Telmisartan—ABCB1—cortex of kidney—kidney cancer	0.000323	0.0106	CbGeAlD
Telmisartan—ABCB1—gonad—kidney cancer	0.000307	0.0101	CbGeAlD
Telmisartan—Candesartan—ABCB1—kidney cancer	0.000246	0.27	CrCbGaD
Telmisartan—Losartan—ABCB1—kidney cancer	0.000159	0.174	CrCbGaD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	8.37e-05	0.000452	CcSEcCtD
Telmisartan—Arrhythmia—Capecitabine—kidney cancer	8.34e-05	0.000451	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Gemcitabine—kidney cancer	8.33e-05	0.00045	CcSEcCtD
Telmisartan—Discomfort—Paclitaxel—kidney cancer	8.33e-05	0.00045	CcSEcCtD
Telmisartan—Fatigue—Gemcitabine—kidney cancer	8.32e-05	0.00045	CcSEcCtD
Telmisartan—Gastrointestinal pain—Vincristine—kidney cancer	8.32e-05	0.00045	CcSEcCtD
Telmisartan—Dizziness—Sorafenib—kidney cancer	8.26e-05	0.000447	CcSEcCtD
Telmisartan—Pain—Gemcitabine—kidney cancer	8.25e-05	0.000446	CcSEcCtD
Telmisartan—Constipation—Gemcitabine—kidney cancer	8.25e-05	0.000446	CcSEcCtD
Telmisartan—Nausea—Erlotinib—kidney cancer	8.25e-05	0.000446	CcSEcCtD
Telmisartan—Dry mouth—Paclitaxel—kidney cancer	8.24e-05	0.000445	CcSEcCtD
Telmisartan—Diarrhoea—Sunitinib—kidney cancer	8.23e-05	0.000445	CcSEcCtD
Telmisartan—Mental disorder—Capecitabine—kidney cancer	8.17e-05	0.000442	CcSEcCtD
Telmisartan—Asthenia—Dactinomycin—kidney cancer	8.17e-05	0.000441	CcSEcCtD
Telmisartan—Blood creatinine increased—Doxorubicin—kidney cancer	8.15e-05	0.00044	CcSEcCtD
Telmisartan—Malnutrition—Capecitabine—kidney cancer	8.12e-05	0.000439	CcSEcCtD
Telmisartan—Erythema—Capecitabine—kidney cancer	8.12e-05	0.000439	CcSEcCtD
Telmisartan—Anaphylactic shock—Paclitaxel—kidney cancer	8.08e-05	0.000437	CcSEcCtD
Telmisartan—Oedema—Paclitaxel—kidney cancer	8.08e-05	0.000437	CcSEcCtD
Telmisartan—Abdominal pain—Vincristine—kidney cancer	8.04e-05	0.000435	CcSEcCtD
Telmisartan—Body temperature increased—Vincristine—kidney cancer	8.04e-05	0.000435	CcSEcCtD
Telmisartan—Infection—Paclitaxel—kidney cancer	8.03e-05	0.000434	CcSEcCtD
Telmisartan—Flatulence—Capecitabine—kidney cancer	8e-05	0.000433	CcSEcCtD
Telmisartan—Dry skin—Doxorubicin—kidney cancer	7.97e-05	0.000431	CcSEcCtD
Telmisartan—Dysgeusia—Capecitabine—kidney cancer	7.95e-05	0.00043	CcSEcCtD
Telmisartan—Dizziness—Sunitinib—kidney cancer	7.95e-05	0.00043	CcSEcCtD
Telmisartan—Feeling abnormal—Gemcitabine—kidney cancer	7.95e-05	0.00043	CcSEcCtD
Telmisartan—Shock—Paclitaxel—kidney cancer	7.95e-05	0.00043	CcSEcCtD
Telmisartan—Vomiting—Sorafenib—kidney cancer	7.95e-05	0.000429	CcSEcCtD
Telmisartan—Orthostatic hypotension—Doxorubicin—kidney cancer	7.94e-05	0.000429	CcSEcCtD
Telmisartan—Nervous system disorder—Paclitaxel—kidney cancer	7.92e-05	0.000428	CcSEcCtD
Telmisartan—Hypokalaemia—Doxorubicin—kidney cancer	7.91e-05	0.000428	CcSEcCtD
Telmisartan—Thrombocytopenia—Paclitaxel—kidney cancer	7.91e-05	0.000428	CcSEcCtD
Telmisartan—Tachycardia—Paclitaxel—kidney cancer	7.88e-05	0.000426	CcSEcCtD
Telmisartan—Rash—Sorafenib—kidney cancer	7.88e-05	0.000426	CcSEcCtD
Telmisartan—Dermatitis—Sorafenib—kidney cancer	7.87e-05	0.000426	CcSEcCtD
Telmisartan—Back pain—Capecitabine—kidney cancer	7.86e-05	0.000425	CcSEcCtD
Telmisartan—Breast disorder—Doxorubicin—kidney cancer	7.86e-05	0.000425	CcSEcCtD
Telmisartan—Skin disorder—Paclitaxel—kidney cancer	7.85e-05	0.000424	CcSEcCtD
Telmisartan—Headache—Sorafenib—kidney cancer	7.83e-05	0.000423	CcSEcCtD
Telmisartan—Muscle spasms—Capecitabine—kidney cancer	7.81e-05	0.000422	CcSEcCtD
Telmisartan—Hyperhidrosis—Paclitaxel—kidney cancer	7.81e-05	0.000422	CcSEcCtD
Telmisartan—Diarrhoea—Dactinomycin—kidney cancer	7.79e-05	0.000421	CcSEcCtD
Telmisartan—Anorexia—Paclitaxel—kidney cancer	7.7e-05	0.000416	CcSEcCtD
Telmisartan—Gastritis—Doxorubicin—kidney cancer	7.69e-05	0.000416	CcSEcCtD
Telmisartan—Muscular weakness—Doxorubicin—kidney cancer	7.67e-05	0.000415	CcSEcCtD
Telmisartan—Vomiting—Sunitinib—kidney cancer	7.65e-05	0.000413	CcSEcCtD
Telmisartan—Body temperature increased—Gemcitabine—kidney cancer	7.63e-05	0.000412	CcSEcCtD
Telmisartan—Rash—Sunitinib—kidney cancer	7.58e-05	0.00041	CcSEcCtD
Telmisartan—Dermatitis—Sunitinib—kidney cancer	7.57e-05	0.000409	CcSEcCtD
Telmisartan—Abdominal distension—Doxorubicin—kidney cancer	7.57e-05	0.000409	CcSEcCtD
Telmisartan—Hypotension—Paclitaxel—kidney cancer	7.55e-05	0.000408	CcSEcCtD
Telmisartan—Ill-defined disorder—Capecitabine—kidney cancer	7.54e-05	0.000407	CcSEcCtD
Telmisartan—Headache—Sunitinib—kidney cancer	7.53e-05	0.000407	CcSEcCtD
Telmisartan—Asthma—Doxorubicin—kidney cancer	7.51e-05	0.000406	CcSEcCtD
Telmisartan—Anaemia—Capecitabine—kidney cancer	7.51e-05	0.000406	CcSEcCtD
Telmisartan—Hypersensitivity—Vincristine—kidney cancer	7.49e-05	0.000405	CcSEcCtD
Telmisartan—Eosinophilia—Doxorubicin—kidney cancer	7.44e-05	0.000402	CcSEcCtD
Telmisartan—Nausea—Sorafenib—kidney cancer	7.42e-05	0.000401	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.36e-05	0.000398	CcSEcCtD
Telmisartan—Malaise—Capecitabine—kidney cancer	7.33e-05	0.000396	CcSEcCtD
Telmisartan—Angina pectoris—Doxorubicin—kidney cancer	7.32e-05	0.000396	CcSEcCtD
Telmisartan—Insomnia—Paclitaxel—kidney cancer	7.31e-05	0.000395	CcSEcCtD
Telmisartan—Vertigo—Capecitabine—kidney cancer	7.3e-05	0.000394	CcSEcCtD
Telmisartan—Asthenia—Vincristine—kidney cancer	7.3e-05	0.000394	CcSEcCtD
Telmisartan—Syncope—Capecitabine—kidney cancer	7.28e-05	0.000394	CcSEcCtD
Telmisartan—Paraesthesia—Paclitaxel—kidney cancer	7.25e-05	0.000392	CcSEcCtD
Telmisartan—Vomiting—Dactinomycin—kidney cancer	7.24e-05	0.000391	CcSEcCtD
Telmisartan—Bronchitis—Doxorubicin—kidney cancer	7.23e-05	0.000391	CcSEcCtD
Telmisartan—Dyspnoea—Paclitaxel—kidney cancer	7.2e-05	0.000389	CcSEcCtD
Telmisartan—Somnolence—Paclitaxel—kidney cancer	7.18e-05	0.000388	CcSEcCtD
Telmisartan—Palpitations—Capecitabine—kidney cancer	7.18e-05	0.000388	CcSEcCtD
Telmisartan—Rash—Dactinomycin—kidney cancer	7.18e-05	0.000388	CcSEcCtD
Telmisartan—Nausea—Sunitinib—kidney cancer	7.14e-05	0.000386	CcSEcCtD
Telmisartan—Loss of consciousness—Capecitabine—kidney cancer	7.14e-05	0.000386	CcSEcCtD
Telmisartan—Dyspepsia—Paclitaxel—kidney cancer	7.11e-05	0.000384	CcSEcCtD
Telmisartan—Cough—Capecitabine—kidney cancer	7.09e-05	0.000383	CcSEcCtD
Telmisartan—Dysuria—Doxorubicin—kidney cancer	7.03e-05	0.00038	CcSEcCtD
Telmisartan—Decreased appetite—Paclitaxel—kidney cancer	7.02e-05	0.00038	CcSEcCtD
Telmisartan—Hypertension—Capecitabine—kidney cancer	7.01e-05	0.000379	CcSEcCtD
Telmisartan—Upper respiratory tract infection—Doxorubicin—kidney cancer	6.98e-05	0.000378	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.97e-05	0.000377	CcSEcCtD
Telmisartan—Fatigue—Paclitaxel—kidney cancer	6.96e-05	0.000376	CcSEcCtD
Telmisartan—Diarrhoea—Vincristine—kidney cancer	6.96e-05	0.000376	CcSEcCtD
Telmisartan—Pollakiuria—Doxorubicin—kidney cancer	6.94e-05	0.000375	CcSEcCtD
Telmisartan—Asthenia—Gemcitabine—kidney cancer	6.92e-05	0.000374	CcSEcCtD
Telmisartan—Arthralgia—Capecitabine—kidney cancer	6.92e-05	0.000374	CcSEcCtD
Telmisartan—Myalgia—Capecitabine—kidney cancer	6.92e-05	0.000374	CcSEcCtD
Telmisartan—Chest pain—Capecitabine—kidney cancer	6.92e-05	0.000374	CcSEcCtD
Telmisartan—Pain—Paclitaxel—kidney cancer	6.91e-05	0.000373	CcSEcCtD
Telmisartan—Constipation—Paclitaxel—kidney cancer	6.91e-05	0.000373	CcSEcCtD
Telmisartan—Anxiety—Capecitabine—kidney cancer	6.89e-05	0.000373	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.87e-05	0.000371	CcSEcCtD
Telmisartan—Discomfort—Capecitabine—kidney cancer	6.83e-05	0.000369	CcSEcCtD
Telmisartan—Pruritus—Gemcitabine—kidney cancer	6.83e-05	0.000369	CcSEcCtD
Telmisartan—Dry mouth—Capecitabine—kidney cancer	6.76e-05	0.000366	CcSEcCtD
Telmisartan—Nausea—Dactinomycin—kidney cancer	6.76e-05	0.000366	CcSEcCtD
Telmisartan—Pneumonia—Doxorubicin—kidney cancer	6.74e-05	0.000364	CcSEcCtD
Telmisartan—Dizziness—Vincristine—kidney cancer	6.73e-05	0.000364	CcSEcCtD
Telmisartan—Infestation NOS—Doxorubicin—kidney cancer	6.7e-05	0.000362	CcSEcCtD
Telmisartan—Infestation—Doxorubicin—kidney cancer	6.7e-05	0.000362	CcSEcCtD
Telmisartan—Feeling abnormal—Paclitaxel—kidney cancer	6.66e-05	0.00036	CcSEcCtD
Telmisartan—Oedema—Capecitabine—kidney cancer	6.63e-05	0.000358	CcSEcCtD
Telmisartan—Gastrointestinal pain—Paclitaxel—kidney cancer	6.61e-05	0.000357	CcSEcCtD
Telmisartan—Diarrhoea—Gemcitabine—kidney cancer	6.6e-05	0.000357	CcSEcCtD
Telmisartan—Renal failure—Doxorubicin—kidney cancer	6.59e-05	0.000356	CcSEcCtD
Telmisartan—Infection—Capecitabine—kidney cancer	6.59e-05	0.000356	CcSEcCtD
Telmisartan—Neuropathy peripheral—Doxorubicin—kidney cancer	6.57e-05	0.000355	CcSEcCtD
Telmisartan—Shock—Capecitabine—kidney cancer	6.52e-05	0.000353	CcSEcCtD
Telmisartan—Conjunctivitis—Doxorubicin—kidney cancer	6.51e-05	0.000352	CcSEcCtD
Telmisartan—Urinary tract infection—Doxorubicin—kidney cancer	6.51e-05	0.000352	CcSEcCtD
Telmisartan—Nervous system disorder—Capecitabine—kidney cancer	6.5e-05	0.000351	CcSEcCtD
Telmisartan—Thrombocytopenia—Capecitabine—kidney cancer	6.49e-05	0.000351	CcSEcCtD
Telmisartan—Tachycardia—Capecitabine—kidney cancer	6.47e-05	0.00035	CcSEcCtD
Telmisartan—Vomiting—Vincristine—kidney cancer	6.47e-05	0.00035	CcSEcCtD
Telmisartan—Skin disorder—Capecitabine—kidney cancer	6.44e-05	0.000348	CcSEcCtD
Telmisartan—Urticaria—Paclitaxel—kidney cancer	6.42e-05	0.000347	CcSEcCtD
Telmisartan—Rash—Vincristine—kidney cancer	6.41e-05	0.000347	CcSEcCtD
Telmisartan—Hyperhidrosis—Capecitabine—kidney cancer	6.41e-05	0.000346	CcSEcCtD
Telmisartan—Dermatitis—Vincristine—kidney cancer	6.41e-05	0.000346	CcSEcCtD
Telmisartan—Haematuria—Doxorubicin—kidney cancer	6.39e-05	0.000345	CcSEcCtD
Telmisartan—Body temperature increased—Paclitaxel—kidney cancer	6.39e-05	0.000345	CcSEcCtD
Telmisartan—Abdominal pain—Paclitaxel—kidney cancer	6.39e-05	0.000345	CcSEcCtD
Telmisartan—Headache—Vincristine—kidney cancer	6.37e-05	0.000344	CcSEcCtD
Telmisartan—Hepatobiliary disease—Doxorubicin—kidney cancer	6.34e-05	0.000343	CcSEcCtD
Telmisartan—Epistaxis—Doxorubicin—kidney cancer	6.32e-05	0.000342	CcSEcCtD
Telmisartan—Anorexia—Capecitabine—kidney cancer	6.32e-05	0.000342	CcSEcCtD
Telmisartan—Sinusitis—Doxorubicin—kidney cancer	6.29e-05	0.00034	CcSEcCtD
Telmisartan—Hypotension—Capecitabine—kidney cancer	6.19e-05	0.000335	CcSEcCtD
Telmisartan—Vomiting—Gemcitabine—kidney cancer	6.13e-05	0.000332	CcSEcCtD
Telmisartan—Bradycardia—Doxorubicin—kidney cancer	6.12e-05	0.000331	CcSEcCtD
Telmisartan—Rash—Gemcitabine—kidney cancer	6.08e-05	0.000329	CcSEcCtD
Telmisartan—Dermatitis—Gemcitabine—kidney cancer	6.08e-05	0.000329	CcSEcCtD
Telmisartan—Headache—Gemcitabine—kidney cancer	6.04e-05	0.000327	CcSEcCtD
Telmisartan—Nausea—Vincristine—kidney cancer	6.04e-05	0.000327	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.04e-05	0.000326	CcSEcCtD
Telmisartan—Rhinitis—Doxorubicin—kidney cancer	6.03e-05	0.000326	CcSEcCtD
Telmisartan—Insomnia—Capecitabine—kidney cancer	6e-05	0.000324	CcSEcCtD
Telmisartan—Hypoaesthesia—Doxorubicin—kidney cancer	5.98e-05	0.000324	CcSEcCtD
Telmisartan—Pharyngitis—Doxorubicin—kidney cancer	5.97e-05	0.000323	CcSEcCtD
Telmisartan—Paraesthesia—Capecitabine—kidney cancer	5.95e-05	0.000322	CcSEcCtD
Telmisartan—Hypersensitivity—Paclitaxel—kidney cancer	5.95e-05	0.000322	CcSEcCtD
Telmisartan—Urinary tract disorder—Doxorubicin—kidney cancer	5.94e-05	0.000321	CcSEcCtD
Telmisartan—Oedema peripheral—Doxorubicin—kidney cancer	5.93e-05	0.00032	CcSEcCtD
Telmisartan—Connective tissue disorder—Doxorubicin—kidney cancer	5.91e-05	0.00032	CcSEcCtD
Telmisartan—Dyspnoea—Capecitabine—kidney cancer	5.91e-05	0.000319	CcSEcCtD
Telmisartan—Urethral disorder—Doxorubicin—kidney cancer	5.9e-05	0.000319	CcSEcCtD
Telmisartan—Dyspepsia—Capecitabine—kidney cancer	5.84e-05	0.000315	CcSEcCtD
Telmisartan—Visual impairment—Doxorubicin—kidney cancer	5.8e-05	0.000313	CcSEcCtD
Telmisartan—Asthenia—Paclitaxel—kidney cancer	5.8e-05	0.000313	CcSEcCtD
Telmisartan—Decreased appetite—Capecitabine—kidney cancer	5.76e-05	0.000312	CcSEcCtD
Telmisartan—Nausea—Gemcitabine—kidney cancer	5.73e-05	0.00031	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Capecitabine—kidney cancer	5.72e-05	0.000309	CcSEcCtD
Telmisartan—Fatigue—Capecitabine—kidney cancer	5.72e-05	0.000309	CcSEcCtD
Telmisartan—Pruritus—Paclitaxel—kidney cancer	5.72e-05	0.000309	CcSEcCtD
Telmisartan—Constipation—Capecitabine—kidney cancer	5.67e-05	0.000306	CcSEcCtD
Telmisartan—Pain—Capecitabine—kidney cancer	5.67e-05	0.000306	CcSEcCtD
Telmisartan—Eye disorder—Doxorubicin—kidney cancer	5.62e-05	0.000304	CcSEcCtD
Telmisartan—Tinnitus—Doxorubicin—kidney cancer	5.61e-05	0.000303	CcSEcCtD
Telmisartan—Cardiac disorder—Doxorubicin—kidney cancer	5.58e-05	0.000302	CcSEcCtD
Telmisartan—Flushing—Doxorubicin—kidney cancer	5.58e-05	0.000302	CcSEcCtD
Telmisartan—Diarrhoea—Paclitaxel—kidney cancer	5.53e-05	0.000299	CcSEcCtD
Telmisartan—Feeling abnormal—Capecitabine—kidney cancer	5.46e-05	0.000295	CcSEcCtD
Telmisartan—Angiopathy—Doxorubicin—kidney cancer	5.46e-05	0.000295	CcSEcCtD
Telmisartan—Immune system disorder—Doxorubicin—kidney cancer	5.43e-05	0.000294	CcSEcCtD
Telmisartan—Gastrointestinal pain—Capecitabine—kidney cancer	5.42e-05	0.000293	CcSEcCtD
Telmisartan—Mediastinal disorder—Doxorubicin—kidney cancer	5.42e-05	0.000293	CcSEcCtD
Telmisartan—Chills—Doxorubicin—kidney cancer	5.4e-05	0.000292	CcSEcCtD
Telmisartan—Arrhythmia—Doxorubicin—kidney cancer	5.37e-05	0.00029	CcSEcCtD
Telmisartan—Dizziness—Paclitaxel—kidney cancer	5.34e-05	0.000289	CcSEcCtD
Telmisartan—Mental disorder—Doxorubicin—kidney cancer	5.27e-05	0.000285	CcSEcCtD
Telmisartan—Urticaria—Capecitabine—kidney cancer	5.27e-05	0.000285	CcSEcCtD
Telmisartan—Abdominal pain—Capecitabine—kidney cancer	5.24e-05	0.000283	CcSEcCtD
Telmisartan—Body temperature increased—Capecitabine—kidney cancer	5.24e-05	0.000283	CcSEcCtD
Telmisartan—Erythema—Doxorubicin—kidney cancer	5.24e-05	0.000283	CcSEcCtD
Telmisartan—Malnutrition—Doxorubicin—kidney cancer	5.24e-05	0.000283	CcSEcCtD
Telmisartan—Flatulence—Doxorubicin—kidney cancer	5.16e-05	0.000279	CcSEcCtD
Telmisartan—Tension—Doxorubicin—kidney cancer	5.14e-05	0.000278	CcSEcCtD
Telmisartan—Vomiting—Paclitaxel—kidney cancer	5.14e-05	0.000278	CcSEcCtD
Telmisartan—Dysgeusia—Doxorubicin—kidney cancer	5.13e-05	0.000277	CcSEcCtD
Telmisartan—Rash—Paclitaxel—kidney cancer	5.09e-05	0.000275	CcSEcCtD
Telmisartan—Dermatitis—Paclitaxel—kidney cancer	5.09e-05	0.000275	CcSEcCtD
Telmisartan—Nervousness—Doxorubicin—kidney cancer	5.09e-05	0.000275	CcSEcCtD
Telmisartan—Back pain—Doxorubicin—kidney cancer	5.06e-05	0.000274	CcSEcCtD
Telmisartan—Headache—Paclitaxel—kidney cancer	5.06e-05	0.000274	CcSEcCtD
Telmisartan—Muscle spasms—Doxorubicin—kidney cancer	5.03e-05	0.000272	CcSEcCtD
Telmisartan—Hypersensitivity—Capecitabine—kidney cancer	4.88e-05	0.000264	CcSEcCtD
Telmisartan—Ill-defined disorder—Doxorubicin—kidney cancer	4.86e-05	0.000263	CcSEcCtD
Telmisartan—Anaemia—Doxorubicin—kidney cancer	4.84e-05	0.000262	CcSEcCtD
Telmisartan—Nausea—Paclitaxel—kidney cancer	4.8e-05	0.000259	CcSEcCtD
Telmisartan—Asthenia—Capecitabine—kidney cancer	4.76e-05	0.000257	CcSEcCtD
Telmisartan—Malaise—Doxorubicin—kidney cancer	4.72e-05	0.000255	CcSEcCtD
Telmisartan—Vertigo—Doxorubicin—kidney cancer	4.7e-05	0.000254	CcSEcCtD
Telmisartan—Syncope—Doxorubicin—kidney cancer	4.7e-05	0.000254	CcSEcCtD
Telmisartan—Pruritus—Capecitabine—kidney cancer	4.69e-05	0.000254	CcSEcCtD
Telmisartan—Palpitations—Doxorubicin—kidney cancer	4.63e-05	0.00025	CcSEcCtD
Telmisartan—Loss of consciousness—Doxorubicin—kidney cancer	4.6e-05	0.000249	CcSEcCtD
Telmisartan—Cough—Doxorubicin—kidney cancer	4.57e-05	0.000247	CcSEcCtD
Telmisartan—Diarrhoea—Capecitabine—kidney cancer	4.54e-05	0.000245	CcSEcCtD
Telmisartan—Hypertension—Doxorubicin—kidney cancer	4.52e-05	0.000244	CcSEcCtD
Telmisartan—Arthralgia—Doxorubicin—kidney cancer	4.46e-05	0.000241	CcSEcCtD
Telmisartan—Chest pain—Doxorubicin—kidney cancer	4.46e-05	0.000241	CcSEcCtD
Telmisartan—Myalgia—Doxorubicin—kidney cancer	4.46e-05	0.000241	CcSEcCtD
Telmisartan—Anxiety—Doxorubicin—kidney cancer	4.44e-05	0.00024	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.43e-05	0.000239	CcSEcCtD
Telmisartan—Discomfort—Doxorubicin—kidney cancer	4.4e-05	0.000238	CcSEcCtD
Telmisartan—Dizziness—Capecitabine—kidney cancer	4.38e-05	0.000237	CcSEcCtD
Telmisartan—Dry mouth—Doxorubicin—kidney cancer	4.36e-05	0.000236	CcSEcCtD
Telmisartan—Anaphylactic shock—Doxorubicin—kidney cancer	4.27e-05	0.000231	CcSEcCtD
Telmisartan—Oedema—Doxorubicin—kidney cancer	4.27e-05	0.000231	CcSEcCtD
Telmisartan—Infection—Doxorubicin—kidney cancer	4.25e-05	0.000229	CcSEcCtD
Telmisartan—Vomiting—Capecitabine—kidney cancer	4.22e-05	0.000228	CcSEcCtD
Telmisartan—Shock—Doxorubicin—kidney cancer	4.2e-05	0.000227	CcSEcCtD
Telmisartan—Nervous system disorder—Doxorubicin—kidney cancer	4.19e-05	0.000227	CcSEcCtD
Telmisartan—Thrombocytopenia—Doxorubicin—kidney cancer	4.18e-05	0.000226	CcSEcCtD
Telmisartan—Rash—Capecitabine—kidney cancer	4.18e-05	0.000226	CcSEcCtD
Telmisartan—Dermatitis—Capecitabine—kidney cancer	4.18e-05	0.000226	CcSEcCtD
Telmisartan—Tachycardia—Doxorubicin—kidney cancer	4.17e-05	0.000225	CcSEcCtD
Telmisartan—Headache—Capecitabine—kidney cancer	4.15e-05	0.000224	CcSEcCtD
Telmisartan—Skin disorder—Doxorubicin—kidney cancer	4.15e-05	0.000224	CcSEcCtD
Telmisartan—Hyperhidrosis—Doxorubicin—kidney cancer	4.13e-05	0.000223	CcSEcCtD
Telmisartan—Anorexia—Doxorubicin—kidney cancer	4.07e-05	0.00022	CcSEcCtD
Telmisartan—Hypotension—Doxorubicin—kidney cancer	3.99e-05	0.000216	CcSEcCtD
Telmisartan—Nausea—Capecitabine—kidney cancer	3.94e-05	0.000213	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.89e-05	0.00021	CcSEcCtD
Telmisartan—Insomnia—Doxorubicin—kidney cancer	3.87e-05	0.000209	CcSEcCtD
Telmisartan—Paraesthesia—Doxorubicin—kidney cancer	3.84e-05	0.000207	CcSEcCtD
Telmisartan—Dyspnoea—Doxorubicin—kidney cancer	3.81e-05	0.000206	CcSEcCtD
Telmisartan—Somnolence—Doxorubicin—kidney cancer	3.8e-05	0.000205	CcSEcCtD
Telmisartan—Dyspepsia—Doxorubicin—kidney cancer	3.76e-05	0.000203	CcSEcCtD
Telmisartan—Decreased appetite—Doxorubicin—kidney cancer	3.71e-05	0.000201	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.69e-05	0.000199	CcSEcCtD
Telmisartan—Fatigue—Doxorubicin—kidney cancer	3.68e-05	0.000199	CcSEcCtD
Telmisartan—Pain—Doxorubicin—kidney cancer	3.65e-05	0.000198	CcSEcCtD
Telmisartan—Constipation—Doxorubicin—kidney cancer	3.65e-05	0.000198	CcSEcCtD
Telmisartan—Feeling abnormal—Doxorubicin—kidney cancer	3.52e-05	0.00019	CcSEcCtD
Telmisartan—Gastrointestinal pain—Doxorubicin—kidney cancer	3.49e-05	0.000189	CcSEcCtD
Telmisartan—Urticaria—Doxorubicin—kidney cancer	3.39e-05	0.000184	CcSEcCtD
Telmisartan—Abdominal pain—Doxorubicin—kidney cancer	3.38e-05	0.000183	CcSEcCtD
Telmisartan—Body temperature increased—Doxorubicin—kidney cancer	3.38e-05	0.000183	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP1A1—kidney cancer	3.16e-05	0.000694	CbGpPWpGaD
Telmisartan—Hypersensitivity—Doxorubicin—kidney cancer	3.15e-05	0.00017	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	3.15e-05	0.000692	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CA9—kidney cancer	3.11e-05	0.000684	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CRABP1—kidney cancer	3.1e-05	0.000682	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.08e-05	0.000677	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.08e-05	0.000677	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.08e-05	0.000677	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPC3—kidney cancer	3.08e-05	0.000677	CbGpPWpGaD
Telmisartan—Asthenia—Doxorubicin—kidney cancer	3.07e-05	0.000166	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.04e-05	0.000669	CbGpPWpGaD
Telmisartan—Pruritus—Doxorubicin—kidney cancer	3.02e-05	0.000163	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.01e-05	0.000661	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA2—kidney cancer	2.99e-05	0.000658	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—GRB7—kidney cancer	2.97e-05	0.000654	CbGpPWpGaD
Telmisartan—Diarrhoea—Doxorubicin—kidney cancer	2.92e-05	0.000158	CcSEcCtD
Telmisartan—ABCG2—Metabolism—ALAD—kidney cancer	2.92e-05	0.000642	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.9e-05	0.000638	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KDR—kidney cancer	2.9e-05	0.000637	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ITPR2—kidney cancer	2.88e-05	0.000634	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—EIF4EBP1—kidney cancer	2.85e-05	0.000627	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HSPB1—kidney cancer	2.85e-05	0.000627	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ST3GAL2—kidney cancer	2.85e-05	0.000626	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MET—kidney cancer	2.83e-05	0.000623	CbGpPWpGaD
Telmisartan—Dizziness—Doxorubicin—kidney cancer	2.83e-05	0.000153	CcSEcCtD
Telmisartan—CYP2C19—Metabolism—ACY1—kidney cancer	2.81e-05	0.000619	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALDH1A1—kidney cancer	2.78e-05	0.000612	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ITPR2—kidney cancer	2.76e-05	0.000608	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ACY1—kidney cancer	2.75e-05	0.000604	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—kidney cancer	2.73e-05	0.000599	CbGpPWpGaD
Telmisartan—Vomiting—Doxorubicin—kidney cancer	2.72e-05	0.000147	CcSEcCtD
Telmisartan—Rash—Doxorubicin—kidney cancer	2.69e-05	0.000146	CcSEcCtD
Telmisartan—Dermatitis—Doxorubicin—kidney cancer	2.69e-05	0.000146	CcSEcCtD
Telmisartan—Headache—Doxorubicin—kidney cancer	2.68e-05	0.000145	CcSEcCtD
Telmisartan—ABCG2—Metabolism—PGK1—kidney cancer	2.67e-05	0.000587	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC5A3—kidney cancer	2.67e-05	0.000587	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.66e-05	0.000585	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—PSMD7—kidney cancer	2.65e-05	0.000583	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CRABP1—kidney cancer	2.65e-05	0.000582	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.64e-05	0.000579	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTT1—kidney cancer	2.63e-05	0.000578	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ACHE—kidney cancer	2.63e-05	0.000578	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—LDHB—kidney cancer	2.62e-05	0.000576	CbGpPWpGaD
Telmisartan—Nausea—Doxorubicin—kidney cancer	2.54e-05	0.000137	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—CTNNA1—kidney cancer	2.51e-05	0.000551	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HSPB1—kidney cancer	2.49e-05	0.000548	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EIF4EBP1—kidney cancer	2.49e-05	0.000548	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SCARB1—kidney cancer	2.49e-05	0.000547	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—kidney cancer	2.48e-05	0.000544	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS1—kidney cancer	2.46e-05	0.000542	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ITPR2—kidney cancer	2.46e-05	0.000541	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PSMD7—kidney cancer	2.42e-05	0.000531	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.4e-05	0.000528	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PDHB—kidney cancer	2.39e-05	0.000526	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—POMC—kidney cancer	2.39e-05	0.000525	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—JUNB—kidney cancer	2.38e-05	0.000523	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PDHB—kidney cancer	2.34e-05	0.000514	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TSC1—kidney cancer	2.32e-05	0.000509	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PSMD7—kidney cancer	2.32e-05	0.000509	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ANXA1—kidney cancer	2.32e-05	0.000509	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.29e-05	0.000504	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—BCHE—kidney cancer	2.29e-05	0.000504	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CA9—kidney cancer	2.27e-05	0.000499	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.27e-05	0.000499	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC5A5—kidney cancer	2.26e-05	0.000498	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CCBL1—kidney cancer	2.25e-05	0.000495	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.25e-05	0.000495	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTT1—kidney cancer	2.24e-05	0.000493	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ACHE—kidney cancer	2.24e-05	0.000493	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FLT1—kidney cancer	2.24e-05	0.000493	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CCBL1—kidney cancer	2.2e-05	0.000483	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC2A1—kidney cancer	2.19e-05	0.000481	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SCARB1—kidney cancer	2.12e-05	0.000467	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.12e-05	0.000466	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—POMC—kidney cancer	2.11e-05	0.000465	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS1—kidney cancer	2.1e-05	0.000462	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—RAF1—kidney cancer	2.09e-05	0.00046	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—RELA—kidney cancer	2.08e-05	0.000458	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—RAF1—kidney cancer	2.08e-05	0.000458	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUNB—kidney cancer	2.08e-05	0.000457	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PAK1—kidney cancer	2.08e-05	0.000457	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—ERBB2—kidney cancer	2.07e-05	0.000456	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PSMD7—kidney cancer	2.06e-05	0.000453	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.03e-05	0.000447	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—BCHE—kidney cancer	1.95e-05	0.00043	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPAT—kidney cancer	1.95e-05	0.000429	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.95e-05	0.000429	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CDKN2B—kidney cancer	1.94e-05	0.000426	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC5A5—kidney cancer	1.93e-05	0.000425	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CRABP1—kidney cancer	1.93e-05	0.000424	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.93e-05	0.000424	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—POMC—kidney cancer	1.92e-05	0.000422	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.91e-05	0.000419	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPAT—kidney cancer	1.9e-05	0.000419	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GLIPR1—kidney cancer	1.9e-05	0.000419	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC2A1—kidney cancer	1.86e-05	0.00041	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.85e-05	0.000407	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTP1—kidney cancer	1.82e-05	0.000401	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—FH—kidney cancer	1.81e-05	0.000399	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APRT—kidney cancer	1.81e-05	0.000399	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—CTNNB1—kidney cancer	1.81e-05	0.000399	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.81e-05	0.000398	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ITPR2—kidney cancer	1.79e-05	0.000394	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.77e-05	0.00039	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APRT—kidney cancer	1.77e-05	0.000389	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—FH—kidney cancer	1.77e-05	0.000389	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.77e-05	0.000388	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.75e-05	0.000384	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ABCB1—kidney cancer	1.73e-05	0.000379	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.71e-05	0.000376	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPC3—kidney cancer	1.71e-05	0.000375	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF2—kidney cancer	1.7e-05	0.000374	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN2B—kidney cancer	1.69e-05	0.000372	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTM1—kidney cancer	1.67e-05	0.000368	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPC3—kidney cancer	1.66e-05	0.000366	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA2—kidney cancer	1.66e-05	0.000365	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IGF1R—kidney cancer	1.64e-05	0.000361	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ACHE—kidney cancer	1.64e-05	0.00036	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTT1—kidney cancer	1.64e-05	0.00036	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.62e-05	0.000357	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA2—kidney cancer	1.62e-05	0.000356	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.62e-05	0.000356	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALAD—kidney cancer	1.62e-05	0.000355	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—kidney cancer	1.6e-05	0.000351	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1A1—kidney cancer	1.59e-05	0.000349	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—RAF1—kidney cancer	1.58e-05	0.000348	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.58e-05	0.000347	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALAD—kidney cancer	1.58e-05	0.000347	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.58e-05	0.000347	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.57e-05	0.000345	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—IL2—kidney cancer	1.56e-05	0.000344	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—MYC—kidney cancer	1.56e-05	0.000343	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTP1—kidney cancer	1.56e-05	0.000342	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SCARB1—kidney cancer	1.55e-05	0.000341	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.54e-05	0.000339	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.54e-05	0.000339	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.54e-05	0.000339	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.54e-05	0.000339	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS1—kidney cancer	1.53e-05	0.000337	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.53e-05	0.000336	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK3—kidney cancer	1.51e-05	0.000332	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.51e-05	0.000331	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PSMD7—kidney cancer	1.5e-05	0.000331	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.49e-05	0.000328	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.49e-05	0.000328	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.48e-05	0.000325	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PGK1—kidney cancer	1.48e-05	0.000325	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—kidney cancer	1.47e-05	0.000324	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—LDHB—kidney cancer	1.45e-05	0.000319	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PGK1—kidney cancer	1.44e-05	0.000317	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A3—kidney cancer	1.44e-05	0.000317	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MAPK1—kidney cancer	1.44e-05	0.000316	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTM1—kidney cancer	1.43e-05	0.000314	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—BCHE—kidney cancer	1.43e-05	0.000313	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL2—kidney cancer	1.42e-05	0.000312	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—LDHB—kidney cancer	1.42e-05	0.000311	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC5A5—kidney cancer	1.41e-05	0.00031	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC2A1—kidney cancer	1.36e-05	0.000299	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—KRAS—kidney cancer	1.36e-05	0.000298	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1A1—kidney cancer	1.35e-05	0.000298	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HIF1A—kidney cancer	1.35e-05	0.000297	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TSC2—kidney cancer	1.35e-05	0.000297	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.35e-05	0.000296	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.3e-05	0.000287	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.3e-05	0.000285	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—kidney cancer	1.29e-05	0.000284	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.27e-05	0.00028	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CA9—kidney cancer	1.26e-05	0.000276	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.24e-05	0.000272	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.23e-05	0.00027	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA9—kidney cancer	1.23e-05	0.00027	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.21e-05	0.000266	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KIT—kidney cancer	1.19e-05	0.000262	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APC—kidney cancer	1.19e-05	0.000262	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—POMC—kidney cancer	1.18e-05	0.00026	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.14e-05	0.000251	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK3—kidney cancer	1.14e-05	0.000251	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—POMC—kidney cancer	1.13e-05	0.000249	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—kidney cancer	1.13e-05	0.000249	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BRAF—kidney cancer	1.12e-05	0.000246	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.11e-05	0.000245	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—MAPK1—kidney cancer	1.09e-05	0.000239	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—kidney cancer	1.07e-05	0.000236	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CRABP1—kidney cancer	1.07e-05	0.000235	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.05e-05	0.000231	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CRABP1—kidney cancer	1.04e-05	0.000229	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—kidney cancer	1.04e-05	0.000229	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PIK3CA—kidney cancer	1.04e-05	0.000228	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—KRAS—kidney cancer	1.03e-05	0.000226	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.02e-05	0.000224	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—POMC—kidney cancer	1.01e-05	0.000222	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ITPR2—kidney cancer	9.94e-06	0.000219	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A1—kidney cancer	9.88e-06	0.000217	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ITPR2—kidney cancer	9.7e-06	0.000213	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—kidney cancer	9.44e-06	0.000208	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PIK3CA—kidney cancer	9.42e-06	0.000207	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RAF1—kidney cancer	9.35e-06	0.000206	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RELA—kidney cancer	9.31e-06	0.000205	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB2—kidney cancer	9.25e-06	0.000203	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.16e-06	0.000201	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MTOR—kidney cancer	9.13e-06	0.000201	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—kidney cancer	9.06e-06	0.000199	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ACHE—kidney cancer	9.06e-06	0.000199	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—kidney cancer	8.84e-06	0.000194	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ACHE—kidney cancer	8.84e-06	0.000194	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SCARB1—kidney cancer	8.58e-06	0.000189	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDKN1B—kidney cancer	8.57e-06	0.000188	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS1—kidney cancer	8.49e-06	0.000187	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL2—kidney cancer	8.39e-06	0.000184	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SCARB1—kidney cancer	8.37e-06	0.000184	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PSMD7—kidney cancer	8.33e-06	0.000183	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS1—kidney cancer	8.29e-06	0.000182	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTEN—kidney cancer	8.23e-06	0.000181	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCND1—kidney cancer	8.18e-06	0.00018	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—kidney cancer	8.16e-06	0.000179	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PSMD7—kidney cancer	8.13e-06	0.000179	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CTNNB1—kidney cancer	8.1e-06	0.000178	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—kidney cancer	8.06e-06	0.000177	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BCHE—kidney cancer	7.89e-06	0.000174	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTEN—kidney cancer	7.89e-06	0.000174	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC5A5—kidney cancer	7.8e-06	0.000171	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MAPK3—kidney cancer	7.72e-06	0.00017	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BCHE—kidney cancer	7.7e-06	0.000169	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC5A5—kidney cancer	7.61e-06	0.000167	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A1—kidney cancer	7.53e-06	0.000166	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—MYC—kidney cancer	7.51e-06	0.000165	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—POMC—kidney cancer	7.36e-06	0.000162	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A1—kidney cancer	7.35e-06	0.000162	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.31e-06	0.000161	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—kidney cancer	7.13e-06	0.000157	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTEN—kidney cancer	7.03e-06	0.000155	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	7.01e-06	0.000154	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK3—kidney cancer	6.74e-06	0.000148	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MYC—kidney cancer	6.56e-06	0.000144	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MAPK1—kidney cancer	6.42e-06	0.000141	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.37e-06	0.00014	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—kidney cancer	6.28e-06	0.000138	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—kidney cancer	6.13e-06	0.000135	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KRAS—kidney cancer	6.06e-06	0.000133	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—kidney cancer	5.95e-06	0.000131	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—kidney cancer	5.87e-06	0.000129	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PIK3CA—kidney cancer	5.81e-06	0.000128	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—kidney cancer	5.77e-06	0.000127	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—kidney cancer	5.63e-06	0.000124	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PIK3CA—kidney cancer	5.57e-06	0.000122	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A1—kidney cancer	5.47e-06	0.00012	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—kidney cancer	5.39e-06	0.000118	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A1—kidney cancer	5.34e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTEN—kidney cancer	5.12e-06	0.000113	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PIK3CA—kidney cancer	4.96e-06	0.000109	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.5e-06	9.88e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—POMC—kidney cancer	4.08e-06	8.97e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—POMC—kidney cancer	3.98e-06	8.76e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PIK3CA—kidney cancer	3.61e-06	7.95e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—kidney cancer	3.25e-06	7.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—kidney cancer	3.18e-06	6.98e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTEN—kidney cancer	2.84e-06	6.24e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTEN—kidney cancer	2.77e-06	6.09e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PIK3CA—kidney cancer	2e-06	4.4e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PIK3CA—kidney cancer	1.95e-06	4.3e-05	CbGpPWpGaD
